SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

Subsidie
€ 1.500.000
2023

Projectdetails

Introduction

Animals and microbes interact in intricate ways. Wolbachia, a common intracellular insect symbiont, can manipulate reproduction and protect hosts from viruses. Thus, Wolbachia is an asset in the control of insect-borne diseases. However, as Wolbachia cannot be cultured outside of host cells or genetically manipulated, the mechanisms of its antiviral phenotype remain poorly understood, and this inhibits wider exploitation.

Research Objectives

I have been working to remedy these deficiencies, and now stand poised to discover the mechanisms of Wolbachia-conferred antiviral protection by answering the following questions:

1. Origin of Protection

Where does the protection originate? Up to now, mechanisms of protection have been studied in whole organisms, often lacking resolution, or in cultured cells, which lack emergent properties. I will identify tissues and cell types of the host where protection starts. To do this, I will:

  • a) Quantify titers of Wolbachia and virus at early time points post-viral infection in insect tissues.
  • b) Measure gene expression of host and microbes to identify candidates for further molecular characterization.
  • c) Test the extent of the utility of widely adopted, yet unvalidated, cell-culture models of antiviral protection.

2. Wolbachia Genes and Protection

Which Wolbachia genes effect protection? Wolbachia research has historically been impeded by a lack of tools to study gene function. Here, I will deploy antisense technology, which I have recently developed, to interrogate the function of candidate Wolbachia genes in the native system. I will also engineer new methods to target Wolbachia genes and proteins, based on my data on cell-penetrating peptide-mediated delivery of bioactive cargo to Wolbachia.

Expected Outcomes

This project has two major outcomes: it will uncover Wolbachia factors responsible for Wolbachia-conferred antiviral protection, and it will transform Wolbachia and symbiosis research by creating tools to study symbiont gene function.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.500.000
Totale projectbegroting€ 1.500.000

Tijdlijn

Startdatum1-1-2023
Einddatum31-12-2027
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • UNIWERSYTET JAGIELLONSKIpenvoerder

Land(en)

Poland

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Exploring the Prokaryotic-Eukaryotic Conservation of Antiviral immunity: from bacterial immune systems to novel antiviral drugs

This project aims to map bacterial antiviral immunity and discover novel anti-phage compounds, potentially transforming our understanding of prokaryotic immune systems and leading to new antiviral therapies.

ERC Starting...€ 1.496.500
2022
Details

PIWI-interacting RNAs at the interface of virus-host conflicts in Aedes aegypti mosquitoes

This project aims to explore the role of piRNAs in protecting mosquito germlines from viruses, enhancing understanding of virus-host interactions and developing strategies for mosquito-borne virus resistance.

ERC Advanced...€ 2.500.000
2024
Details

Evolutionary immunology: using insect models to unravel STING-dependent conserved and innovative antiviral strategies

This project aims to explore antiviral gene diversity in insects, leveraging cGAMP-triggered responses in Drosophila to identify novel antiviral mechanisms for potential therapeutic applications.

ERC Advanced...€ 2.396.099
2025
Details

Archaeal Virology: unravelling the mechanisms of interviral warfare

This project aims to investigate viral mechanisms that enable competition among viruses infecting archaea, with potential applications in enhancing human health and reducing methane emissions.

ERC Starting...€ 1.500.000
2022
Details

Molecular dissection of viral genomes for future antiviral treatments

This project aims to identify and characterize virus-encoded transmembrane proteins as novel pharmaceutical targets for antiviral drug discovery and treatment of viral infections.

ERC Advanced...€ 2.420.301
2023
Details
ERC Starting...

Exploring the Prokaryotic-Eukaryotic Conservation of Antiviral immunity: from bacterial immune systems to novel antiviral drugs

This project aims to map bacterial antiviral immunity and discover novel anti-phage compounds, potentially transforming our understanding of prokaryotic immune systems and leading to new antiviral therapies.

ERC Starting Grant
€ 1.496.500
2022
Details
ERC Advanced...

PIWI-interacting RNAs at the interface of virus-host conflicts in Aedes aegypti mosquitoes

This project aims to explore the role of piRNAs in protecting mosquito germlines from viruses, enhancing understanding of virus-host interactions and developing strategies for mosquito-borne virus resistance.

ERC Advanced Grant
€ 2.500.000
2024
Details
ERC Advanced...

Evolutionary immunology: using insect models to unravel STING-dependent conserved and innovative antiviral strategies

This project aims to explore antiviral gene diversity in insects, leveraging cGAMP-triggered responses in Drosophila to identify novel antiviral mechanisms for potential therapeutic applications.

ERC Advanced Grant
€ 2.396.099
2025
Details
ERC Starting...

Archaeal Virology: unravelling the mechanisms of interviral warfare

This project aims to investigate viral mechanisms that enable competition among viruses infecting archaea, with potential applications in enhancing human health and reducing methane emissions.

ERC Starting Grant
€ 1.500.000
2022
Details
ERC Advanced...

Molecular dissection of viral genomes for future antiviral treatments

This project aims to identify and characterize virus-encoded transmembrane proteins as novel pharmaceutical targets for antiviral drug discovery and treatment of viral infections.

ERC Advanced Grant
€ 2.420.301
2023
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.